Arrowhead Pharmaceuticals, Inc. (ARWR)

Healthcare · Biotechnology · NASDAQ

Arrowhead Pharmaceuticals, Inc. (ARWR) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $12.38B and a free-cash-flow yield of 1.3%. Over the most recent reported fiscal year, revenue grew 23258.2%.

Market cap	$12.38B
Trailing P/E	—
FCF yield	1.3%
Revenue growth (YoY)	+23258.2%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ARWR data on Nama Insights →

Recent Congressional trades

Arrowhead Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Daniel Goldman	House	Sell	$1,001 - $15,000	Feb 9, 2023